Which adults with advanced non-small cell lung cancer is alectinib hydrochloride (Alecensa) indicated to treat?

Alecensa (alectinib hydrochloride) is indicated as monotherapy for adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer, either as first-line treatment or after previous treatment with crizotinib.